Ann: Investor Presentation, page-33

Hi Silverfox, I would have to slightly disagree, not in a bad way as I really enjoy your posts, but to me this was not just a presentation. I think this was a great start to multiple announcements due out this month. Don't get me wrong, there was plenty of old stuff recycled for "presentation" purpose which is always nice to see but there were a few things in there I think that would continue the validate the progress towards the FDA and beyond.

I think a some of the Info is just generalized around Disease and telehealth numbers. Very similar number crunching to previous announcements and always there to remind people the potential of this software (Hmm lets see 700M Visits PA x $5), Stuff you can find easily yourself. the real juice lays in what we are invested in and the details relating to that. the below are some details I took out of that which really show me the direction, drive and outcomes the company is looking at for us. Also that everything is still on track.

1) Confirmation that we should have at least 3 more critical pieces of information supplied to us by the end of the quarter, Approval and commence enrollment at second hospital site for adult clinical study. Report updated results from pediatric clinical study. Meeting with FDA to discuss Pre-Submission filing.

2) Initiated adult clinical study . Enrollment in adult clinical study progressing quickly, second site online in Q1 2016

3) On-track to bring product to market in late 2016, launch via telehealth partner to reach
millions of patients quickly -

4)Developed high performance cross-platform software library that can be deployed via
smartphone app, SDK or cloud-hosted Software-as-a-Service API

5) Built up the team with three new hires (software development, clinical/regulatory
operations)

6) Over 500 pediatric patients enrolled to date (@ Joondalup and PMH)

To be honest am still surprised this has such low Mcap. Med/Long Term this is only heading in one direction!